CBL vs DOC

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

CBL

CTRLBIONIC FPO [CBL]

53MEDIUM

DOC

DOCTORCARE CDI 1:1 [DOC]

53MEDIUM

Score Breakdown

CBL DOC
Technical
77
48
Catalyst
50
50
Sentiment
50
50
Fundamental
55
88
Momentum
75
68
Risk Gate
50
50

Key Metrics

CBL Metric DOC
$23.9MMarket Cap$49.5M
247KAvg Volume (20d)206K
N/AShort InterestN/A
$0.08652-Week High$0.210
$0.02652-Week Low$0.080
+1.8%Daily Change+8.0%
$0.058Entry Price$0.135
-91.6%ROE+617.6%
-107.0%Profit Margin+3.0%

Active Signals

CBL Signals

●MACD momentum is picking up steam
●Above-average volume (1.9x) on a green day — buyers stepping up
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Low cash runway (3 quarters) - dilution risk
●Low P/S ratio (3.9x)
●Piotroski F-Score weak (3/9, low-confidence approx)
●Small-cap ($20-100M)

DOC Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic just turned bullish from a low level — early reversal sign
●Trading below both moving averages — the trend is working against this one
●Volume surging at 2.1x normal while price falls — heavy selling pressure
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-01-28
●Low P/S ratio (1.3x)

Ask Scout AI to compare CBL and DOC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
CBL Full Analysis → DOC Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).